secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2023-03-20T23:59:59+00:00
Accession:  0001104659-23-034342
Event type: debt
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Acura Pharmaceuticals secures $250K related-party loan; warns of possible operations cessation
--------------------------------------------------------------------------------

- Received $250,000 loan from AD Pharma, controlled by Mr. Schutte, increasing total debt to $3,319,279 at 5.25% interest, maturing Dec 31, 2023.
- Proceeds will fund operations only through April 2023; warns that without additional financing it may scale back or cease operations.
- AD Pharma directly owns ~66% of common stock; Mr. Schutte owns ~14% directly; loan is a related-party transaction.
- Default interest rate of 7.5% applies to overdue amounts; events of default include bankruptcy and payment failure for 5 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465923034342/0001104659-23-034342-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465923034342/tm2310020d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-034342

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer